Latest filing published 23 Jun 2026 for BeOne Medicines Ltd., €820k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
John Oyler: trading record in brief
John Oyler is a declared insider of BeOne Medicines Ltd., with filings sourced from SEC (Form 4). Between 8 June 2026 and 23 June 2026, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 23 June 2026 came the latest disclosure, a transaction for €820k in BeOne Medicines Ltd. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Oyler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,410 shares@ US$273.78070.0030% mcap100.0% of flowADSSEC144:0001950047-26-006411
- 3,693 shares@ US$265.5528ADSSEC144:0001950047-26-006178
- 1,949 shares@ US$257.2369ADSSEC144:0001950047-26-005928
3 of 3 declarations
